Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Return on Sales (2020 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Return on Sales for 6 consecutive years, with 0.01% as the latest value for Q1 2025.

  • Quarterly Return on Sales rose 3961.0% to 0.01% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2025, up 3961.0% year-over-year, with the annual reading at 0.12% for FY2024, 3458.0% up from the prior year.
  • Return on Sales for Q1 2025 was 0.01% at Fulcrum Therapeutics, up from 0.12% in the prior quarter.
  • The five-year high for Return on Sales was 0.69% in Q2 2024, with the low at 84.0% in Q1 2023.
  • Average Return on Sales over 5 years is 18.44%, with a median of 10.0% recorded in 2022.
  • The sharpest move saw Return on Sales tumbled -7399bps in 2023, then surged 4438bps in 2024.
  • Over 5 years, Return on Sales stood at 4.64% in 2021, then crashed by -722bps to 38.15% in 2022, then increased by 26bps to 28.42% in 2023, then surged by 100bps to 0.12% in 2024, then surged by 95bps to 0.01% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.01%, 0.12%, and 0.22% for Q1 2025, Q4 2024, and Q3 2024 respectively.